Paragon BioTeck specializes in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies for eye diseases... Read more
Paragonbioteck President & CEO: Patrick Witham

President & CEO

Patrick Witham

CEO Approval Rating

70/100

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
1-25
Agree?
Funding
$350K
Acquisitions
1

Trending Companies